Table of Contents Table of Contents
Previous Page  635 / 1726 Next Page
Information
Show Menu
Previous Page 635 / 1726 Next Page
Page Background

Stage I high-intermediate risk (n = 427)

R

pelvic radiotherapy

vaginal brachytherapy

2

Nout et al, Lancet 2010

46 Gy / 23# / 5 wks

21 Gy / 3# / 2 wks

age > 60 and ≥50% invasion grd 1-2 or <50% invasion grd 3

FIGO 1988 stage 2A

TAH-BSO

without lymphadenectomy

PORTEC-2 trial (2002-2006)